Lebar; Matthew

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lebar; Matthew.The latest application filed is for "modified lipopolysaccharide glycoform and method of use".

Company Profile

4.11.8

Lebar; Matthew - Mandeville LA
Lebar; Matthew - Boston MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modified lipopolysaccharide glycoform and method of use Grant 10,864,266 - Silhavy , et al. December 15, 2	2020-12-15
Modified Lipopolysaccharide Glycoform And Method Of Use App 20200121786 - Silhavy; Thomas J. ; et al.	2020-04-23
Modified lipopolysaccharide glycoform and method of use Grant 10,525,126 - Silhavy , et al. J	2020-01-07
Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases Grant 10,358,405 - Dickey , et al. July 23, 2	2019-07-23
Myricanol Derivatives and Uses Thereof for Treatment of Neurodegenerative Diseases App 20190218165 - Dickey; Chad ; et al.	2019-07-18
Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases Grant 10,287,227 - Dickey , et al.	2019-05-14
Myricanol Derivatives and Uses Thereof for Treatment of Neurodegenerative Diseases App 20180265442 - Dickey; Chad ; et al.	2018-09-20
Myricanol Derivatives and Uses Thereof for Treatment of Neurodegenerative Diseases App 20180037529 - Dickey; Chad ; et al.	2018-02-08
Modified Lipopolysaccharide Glycoform And Method Of Use App 20170239350 - Silhavy; Thomas J. ; et al.	2017-08-24
Modified lipopolysaccharide glycoform and method of use Grant 9,677,052 - Silhavy , et al. June 13, 2	2017-06-13
Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases Grant 9,598,338 - Dickey , et al. March 21, 2	2017-03-21
Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases Grant 9,206,103 - Dickey , et al. December 8, 2	2015-12-08
Materials And Methods For Reduction Of Protein Tau And Treatment Of Neurodegenerative Diseases App 20150072029 - DICKEY; Chad ; et al.	2015-03-12
Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases Grant 8,940,945 - Dickey , et al. January 27, 2	2015-01-27
Materials And Methods For Reduction Of Protein Tau And Treatment Of Neurodegenerative Diseases App 20130184353 - Dickey; Chad ; et al.	2013-07-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.